Fortune magazine has predicted that 2023 will be the ‘year of the digital assassin’. Rescreening employees to mitigate against the risks of reputational and financial damage is a useful tactic, ...

PSA-based prostate cancer screening is widely known to be controversial, mainly owing to the characteristics of the disease and the performance characteristics of the available screening tests that ...